These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27080352)

  • 1. MANAGEMENT OF ENDOCRINE DISEASE: Recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis.
    Amar L; Lussey-Lepoutre C; Lenders JW; Djadi-Prat J; Plouin PF; Steichen O
    Eur J Endocrinol; 2016 Oct; 175(4):R135-45. PubMed ID: 27080352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s).
    van Heerden JA; Roland CF; Carney JA; Sheps SG; Grant CS
    World J Surg; 1990; 14(3):325-9. PubMed ID: 1973322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma.
    Amar L; Fassnacht M; Gimenez-Roqueplo AP; Januszewicz A; Prejbisz A; Timmers H; Plouin PF
    Horm Metab Res; 2012 May; 44(5):385-9. PubMed ID: 22351478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy.
    Parasiliti-Caprino M; Lucatello B; Lopez C; Burrello J; Maletta F; Mistrangelo M; Migliore E; Tassone F; La Grotta A; Pia A; Reimondo G; Giordano R; Giraudo G; Piovesan A; Ciccone G; Deandreis D; Limone P; Orlandi F; Borretta G; Volante M; Mulatero P; Papotti M; Aimaretti G; Terzolo M; Morino M; Pasini B; Veglio F; Ghigo E; Arvat E; Maccario M
    Hypertens Res; 2020 Jun; 43(6):500-510. PubMed ID: 31586159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior mediastinal paraganglioma with bilateral adrenal pheochromocytoma.
    Kwon HJ; Park JH; Jin GY; Chung MJ; Lim ST; Kim MH; Kim HJ; Lee YC
    Respir Med; 2004 Jun; 98(6):574-6. PubMed ID: 15191044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas.
    Walz MK; Peitgen K; Neumann HP; Janssen OE; Philipp T; Mann K
    World J Surg; 2002 Aug; 26(8):1005-12. PubMed ID: 12045858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Treatment of Malignant Pheochromocytoma and Paraganglioma: Retrospective Case Series.
    Strajina V; Dy BM; Farley DR; Richards ML; McKenzie TJ; Bible KC; Que FG; Nagorney DM; Young WF; Thompson GB
    Ann Surg Oncol; 2017 Jun; 24(6):1546-1550. PubMed ID: 28058556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraganglioma: not just an extra-adrenal pheochromocytoma.
    Laird AM; Gauger PG; Doherty GM; Miller BS
    Langenbecks Arch Surg; 2012 Feb; 397(2):247-53. PubMed ID: 22086065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical spectrum and outcome of functional extraadrenal paraganglioma.
    O'Riordain DS; Young WF; Grant CS; Carney JA; van Heerden JA
    World J Surg; 1996 Sep; 20(7):916-21; discussion 922. PubMed ID: 8678971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic resection of periadrenal paraganglioma in a patient with multiple endocrine neoplasia type 2A.
    Nomura T; Takahashi M; Ando T; Sato F; Fujii S; Mimata H
    Surg Laparosc Endosc Percutan Tech; 2011 Feb; 21(1):e31-3. PubMed ID: 21304370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service.
    Kim JH; Moon H; Noh J; Lee J; Kim SG
    Endocrinol Metab (Seoul); 2020 Mar; 35(1):157-164. PubMed ID: 32207276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center.
    Pham TH; Moir C; Thompson GB; Zarroug AE; Hamner CE; Farley D; van Heerden J; Lteif AN; Young WF
    Pediatrics; 2006 Sep; 118(3):1109-17. PubMed ID: 16951005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 producing pheochromocytoma/paraganglioma: case series from a tertiary referral centre for pheochromocytomas and paragangliomas.
    Meijs AC; Schroijen MA; Snel M; Corssmit EPM
    J Endocrinol Invest; 2021 Oct; 44(10):2253-2259. PubMed ID: 33715142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and surgical treatment of extra-adrenal pheochromocytoma].
    Hiller WF; Scheumann GF; Dralle H
    Chirurg; 1993 Jan; 64(1):36-42. PubMed ID: 8436047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local-Regional Recurrence of Pheochromocytoma/Paraganglioma: Characteristics, Risk Factors and Outcomes.
    Cui Y; Ma X; Gao Y; Chang X; Chen S; Lu L; Tong A
    Front Endocrinol (Lausanne); 2021; 12():762548. PubMed ID: 34899602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence Rate of Sporadic Pheochromocytomas After Curative Adrenalectomy: A Systematic Review and Meta-analysis.
    Holscher I; van den Berg TJ; Dreijerink KMA; Engelsman AF; Nieveen van Dijkum EJM
    J Clin Endocrinol Metab; 2021 Jan; 106(2):588-597. PubMed ID: 33125073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma.
    Roman-Gonzalez A; Zhou S; Ayala-Ramirez M; Shen C; Waguespack SG; Habra MA; Karam JA; Perrier N; Wood CG; Jimenez C
    Ann Surg; 2018 Jul; 268(1):172-178. PubMed ID: 28257320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas.
    Araujo-Castro M; García Sanz I; Mínguez Ojeda C; Hanzu F; Mora M; Vicente A; Blanco Carrera C; de Miguel Novoa P; López García MDC; Lamas C; Manjón-Miguélez L; Del Castillo Tous M; Rodríguez de Vera P; Barahona San Millán R; Recasens M; Tomé Fernández-Ladreda M; Valdés N; Gracia Gimeno P; Robles Lazaro C; Michalopoulou T; Álvarez Escolá C; García Centeno R; Barca-Tierno V; Herrera-Martínez AD; Calatayud M
    Front Endocrinol (Lausanne); 2023; 14():1279828. PubMed ID: 38155946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1.
    Butz JJ; Yan Q; McKenzie TJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
    Surgery; 2017 Dec; 162(6):1259-1269. PubMed ID: 28919049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.
    Ayala-Ramirez M; Feng L; Johnson MM; Ejaz S; Habra MA; Rich T; Busaidy N; Cote GJ; Perrier N; Phan A; Patel S; Waguespack S; Jimenez C
    J Clin Endocrinol Metab; 2011 Mar; 96(3):717-25. PubMed ID: 21190975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.